Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice

•The development of H. pylori vaccine became a priority in the field of vaccinology.•The research was aimed at determining the role of some cytokines in H. pylori vaccine development.•Either oipA alone, or oipA co-expressed with cytokines, promotes protective immunity.•The highest Th17 cytokines wer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytokine (Philadelphia, Pa.) Pa.), 2020-02, Vol.126, p.154866-154866, Article 154866
Hauptverfasser: Nemattalab, Mehran, Shenagari, Mohammad, Taheri, Mojtaba, Mahjoob, Mohammad, Nazari Chamaki, Foroogh, Mojtahedi, Ali, Hasan-alizadeh, Elham, Ashrafkhani, Babak, Mousavi Niri, Neda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 154866
container_issue
container_start_page 154866
container_title Cytokine (Philadelphia, Pa.)
container_volume 126
creator Nemattalab, Mehran
Shenagari, Mohammad
Taheri, Mojtaba
Mahjoob, Mohammad
Nazari Chamaki, Foroogh
Mojtahedi, Ali
Hasan-alizadeh, Elham
Ashrafkhani, Babak
Mousavi Niri, Neda
description •The development of H. pylori vaccine became a priority in the field of vaccinology.•The research was aimed at determining the role of some cytokines in H. pylori vaccine development.•Either oipA alone, or oipA co-expressed with cytokines, promotes protective immunity.•The highest Th17 cytokines were produced in Treg suppressed IL-17A receiving group.•Treg suppressed mice administered with IL-17A/oipA developed sterile immunity. The increasing clinical significance of Helicobacter pylori (H. pylori) in human stomach cancer has led to global efforts to eradicate this pathogen. Recent studies have confirmed the importance of some cytokines such as Interleukin-18 (IL-18), Interleukin-8 (IL-8), Interleukin-17A (IL-17A) and Interleukin-22 (IL-22) in the pathogenesis of the so-called bacterium. This study was designed to compare the effects of Type 1T helper (Th1), Type 2T helper (Th2) cells, Regulatory T cells (Treg) and T helper 17 (Th17) modulatory effects on the efficacy of designed H. pylori vaccine by incorporating some molecular adjuvants in Treg competent and Treg suppressed groups. A bicistronic vector was used for simultaneous expression of codon-optimized Outer inflammatory protein a (OipA) gene and modified mice IL-18, IL-17A, IL-22 and Foxp3 (forkhead box P3) cytokines from four cassettes. Immunization of mice groups was performed using produced plasmids intradermally. Specific IgG1 and IgG2 and IgA antibody titers produced in mice were confirmed by enzyme-linked immunosorbent assay (ELISA) in sera and intestine obtained four weeks after the last immunization. After being stimulated with a mixture of both anti-CD28 mAb and H. pylori lysate, frequencies of single Interferon-Gamma (IFN-γ), single IL-17 and dual IFN-γ/IL-17-secreting T-cells were documented using dual-color FluoroSpot. The kinetics of Th1, Th2 and Th17 in the immunized animals was determined by relative quantification of IL-17A, IL-22, IFN-γ, IL-8, IL-2 and IL-4 specific mRNAs. Four weeks after bacterial challenge, quantitative colony count in the isolated and homogenized stomachs was utilized to assess the level of protective immunity among all groups. The results of immunologic assays showed that the highest cell-mediated immunity cytokines were produced in IL-17 receiving group in which the Treg responses were suppressed previously by the administration of the Foxp3 as an immunogen. In addition, potent clearance of Helicobacter pylori infection was seen in this group as well.
doi_str_mv 10.1016/j.cyto.2019.154866
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2307137192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043466619302959</els_id><sourcerecordid>2307137192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-c07682e15f78599b54c1266eb631c5770e463b773e31b448084e3161d22118ce3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQhy0EoqXwAhyQj1yy-E9iJxKXagW0UiUu5Ww5k9nixbGDHa-ah-FdSdjCkdPMyN_85NFHyFvOdpxx9eG4g2WOO8F4t-NN3Sr1jFxy1qmKMSGfb30tq1opdUFe5XxkjHVS65fkQnIlOs7kJfm1jxU-TglzdjHQeKC3YcbksfxwoeL6mo7RIxRvE7XDsZxsmKkNA51SnL4v3sLsgN6gdxD7dcBEp8XH5OgDBtzeThbABaQQix8o2JKR5pVzHqkbxxLcvFAX6H3CB5rL9OcvONDRAb4mLw7WZ3zzVK_It8-f7vc31d3XL7f767sKZKPmCphWrUDeHHTbdF3f1MCFUtgryaHRmmGtZK-1RMn7um5ZW6-d4oMQnLeA8oq8P-euV_0smGczugzovQ0YSzZCMs2l5p1YUXFGIcWcEx7MlNxo02I4M5sWczSbFrNpMWct69K7p_zSjzj8W_nrYQU-ngFcrzw5TCaDwwA4uIQwmyG6_-X_Bn1soKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2307137192</pqid></control><display><type>article</type><title>Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Nemattalab, Mehran ; Shenagari, Mohammad ; Taheri, Mojtaba ; Mahjoob, Mohammad ; Nazari Chamaki, Foroogh ; Mojtahedi, Ali ; Hasan-alizadeh, Elham ; Ashrafkhani, Babak ; Mousavi Niri, Neda</creator><creatorcontrib>Nemattalab, Mehran ; Shenagari, Mohammad ; Taheri, Mojtaba ; Mahjoob, Mohammad ; Nazari Chamaki, Foroogh ; Mojtahedi, Ali ; Hasan-alizadeh, Elham ; Ashrafkhani, Babak ; Mousavi Niri, Neda</creatorcontrib><description>•The development of H. pylori vaccine became a priority in the field of vaccinology.•The research was aimed at determining the role of some cytokines in H. pylori vaccine development.•Either oipA alone, or oipA co-expressed with cytokines, promotes protective immunity.•The highest Th17 cytokines were produced in Treg suppressed IL-17A receiving group.•Treg suppressed mice administered with IL-17A/oipA developed sterile immunity. The increasing clinical significance of Helicobacter pylori (H. pylori) in human stomach cancer has led to global efforts to eradicate this pathogen. Recent studies have confirmed the importance of some cytokines such as Interleukin-18 (IL-18), Interleukin-8 (IL-8), Interleukin-17A (IL-17A) and Interleukin-22 (IL-22) in the pathogenesis of the so-called bacterium. This study was designed to compare the effects of Type 1T helper (Th1), Type 2T helper (Th2) cells, Regulatory T cells (Treg) and T helper 17 (Th17) modulatory effects on the efficacy of designed H. pylori vaccine by incorporating some molecular adjuvants in Treg competent and Treg suppressed groups. A bicistronic vector was used for simultaneous expression of codon-optimized Outer inflammatory protein a (OipA) gene and modified mice IL-18, IL-17A, IL-22 and Foxp3 (forkhead box P3) cytokines from four cassettes. Immunization of mice groups was performed using produced plasmids intradermally. Specific IgG1 and IgG2 and IgA antibody titers produced in mice were confirmed by enzyme-linked immunosorbent assay (ELISA) in sera and intestine obtained four weeks after the last immunization. After being stimulated with a mixture of both anti-CD28 mAb and H. pylori lysate, frequencies of single Interferon-Gamma (IFN-γ), single IL-17 and dual IFN-γ/IL-17-secreting T-cells were documented using dual-color FluoroSpot. The kinetics of Th1, Th2 and Th17 in the immunized animals was determined by relative quantification of IL-17A, IL-22, IFN-γ, IL-8, IL-2 and IL-4 specific mRNAs. Four weeks after bacterial challenge, quantitative colony count in the isolated and homogenized stomachs was utilized to assess the level of protective immunity among all groups. The results of immunologic assays showed that the highest cell-mediated immunity cytokines were produced in IL-17 receiving group in which the Treg responses were suppressed previously by the administration of the Foxp3 as an immunogen. In addition, potent clearance of Helicobacter pylori infection was seen in this group as well.</description><identifier>ISSN: 1043-4666</identifier><identifier>EISSN: 1096-0023</identifier><identifier>DOI: 10.1016/j.cyto.2019.154866</identifier><identifier>PMID: 31629103</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adjuvants, Immunologic ; Animals ; Helicobacter Infections - prevention &amp; control ; Helicobacter pylori ; Helicobacter pylori - immunology ; Hepatocyte Nuclear Factor 3-gamma - immunology ; IL-17A ; IL-18 ; IL-22 ; Immunoglobulin G - blood ; Interferon-gamma - blood ; Interferon-gamma - genetics ; Interferon-gamma - metabolism ; Interleukin-17 - blood ; Interleukin-17 - genetics ; Interleukin-17 - metabolism ; Interleukin-18 - blood ; Interleukin-18 - genetics ; Interleukin-18 - metabolism ; Interleukin-2 - blood ; Interleukin-2 - genetics ; Interleukin-22 ; Interleukin-4 - blood ; Interleukin-4 - genetics ; Interleukin-8 - blood ; Interleukin-8 - genetics ; Interleukins - blood ; Interleukins - genetics ; Interleukins - metabolism ; Mice ; Recombinant Proteins ; T-Lymphocytes, Regulatory - immunology ; T-Lymphocytes, Regulatory - metabolism ; Th1 Cells - immunology ; Th17 Cells - immunology ; Th2 Cells - immunology ; Treg ; Vaccine ; Vaccines - immunology</subject><ispartof>Cytokine (Philadelphia, Pa.), 2020-02, Vol.126, p.154866-154866, Article 154866</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-c07682e15f78599b54c1266eb631c5770e463b773e31b448084e3161d22118ce3</citedby><cites>FETCH-LOGICAL-c356t-c07682e15f78599b54c1266eb631c5770e463b773e31b448084e3161d22118ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1043466619302959$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31629103$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nemattalab, Mehran</creatorcontrib><creatorcontrib>Shenagari, Mohammad</creatorcontrib><creatorcontrib>Taheri, Mojtaba</creatorcontrib><creatorcontrib>Mahjoob, Mohammad</creatorcontrib><creatorcontrib>Nazari Chamaki, Foroogh</creatorcontrib><creatorcontrib>Mojtahedi, Ali</creatorcontrib><creatorcontrib>Hasan-alizadeh, Elham</creatorcontrib><creatorcontrib>Ashrafkhani, Babak</creatorcontrib><creatorcontrib>Mousavi Niri, Neda</creatorcontrib><title>Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice</title><title>Cytokine (Philadelphia, Pa.)</title><addtitle>Cytokine</addtitle><description>•The development of H. pylori vaccine became a priority in the field of vaccinology.•The research was aimed at determining the role of some cytokines in H. pylori vaccine development.•Either oipA alone, or oipA co-expressed with cytokines, promotes protective immunity.•The highest Th17 cytokines were produced in Treg suppressed IL-17A receiving group.•Treg suppressed mice administered with IL-17A/oipA developed sterile immunity. The increasing clinical significance of Helicobacter pylori (H. pylori) in human stomach cancer has led to global efforts to eradicate this pathogen. Recent studies have confirmed the importance of some cytokines such as Interleukin-18 (IL-18), Interleukin-8 (IL-8), Interleukin-17A (IL-17A) and Interleukin-22 (IL-22) in the pathogenesis of the so-called bacterium. This study was designed to compare the effects of Type 1T helper (Th1), Type 2T helper (Th2) cells, Regulatory T cells (Treg) and T helper 17 (Th17) modulatory effects on the efficacy of designed H. pylori vaccine by incorporating some molecular adjuvants in Treg competent and Treg suppressed groups. A bicistronic vector was used for simultaneous expression of codon-optimized Outer inflammatory protein a (OipA) gene and modified mice IL-18, IL-17A, IL-22 and Foxp3 (forkhead box P3) cytokines from four cassettes. Immunization of mice groups was performed using produced plasmids intradermally. Specific IgG1 and IgG2 and IgA antibody titers produced in mice were confirmed by enzyme-linked immunosorbent assay (ELISA) in sera and intestine obtained four weeks after the last immunization. After being stimulated with a mixture of both anti-CD28 mAb and H. pylori lysate, frequencies of single Interferon-Gamma (IFN-γ), single IL-17 and dual IFN-γ/IL-17-secreting T-cells were documented using dual-color FluoroSpot. The kinetics of Th1, Th2 and Th17 in the immunized animals was determined by relative quantification of IL-17A, IL-22, IFN-γ, IL-8, IL-2 and IL-4 specific mRNAs. Four weeks after bacterial challenge, quantitative colony count in the isolated and homogenized stomachs was utilized to assess the level of protective immunity among all groups. The results of immunologic assays showed that the highest cell-mediated immunity cytokines were produced in IL-17 receiving group in which the Treg responses were suppressed previously by the administration of the Foxp3 as an immunogen. In addition, potent clearance of Helicobacter pylori infection was seen in this group as well.</description><subject>Adjuvants, Immunologic</subject><subject>Animals</subject><subject>Helicobacter Infections - prevention &amp; control</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - immunology</subject><subject>Hepatocyte Nuclear Factor 3-gamma - immunology</subject><subject>IL-17A</subject><subject>IL-18</subject><subject>IL-22</subject><subject>Immunoglobulin G - blood</subject><subject>Interferon-gamma - blood</subject><subject>Interferon-gamma - genetics</subject><subject>Interferon-gamma - metabolism</subject><subject>Interleukin-17 - blood</subject><subject>Interleukin-17 - genetics</subject><subject>Interleukin-17 - metabolism</subject><subject>Interleukin-18 - blood</subject><subject>Interleukin-18 - genetics</subject><subject>Interleukin-18 - metabolism</subject><subject>Interleukin-2 - blood</subject><subject>Interleukin-2 - genetics</subject><subject>Interleukin-22</subject><subject>Interleukin-4 - blood</subject><subject>Interleukin-4 - genetics</subject><subject>Interleukin-8 - blood</subject><subject>Interleukin-8 - genetics</subject><subject>Interleukins - blood</subject><subject>Interleukins - genetics</subject><subject>Interleukins - metabolism</subject><subject>Mice</subject><subject>Recombinant Proteins</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><subject>T-Lymphocytes, Regulatory - metabolism</subject><subject>Th1 Cells - immunology</subject><subject>Th17 Cells - immunology</subject><subject>Th2 Cells - immunology</subject><subject>Treg</subject><subject>Vaccine</subject><subject>Vaccines - immunology</subject><issn>1043-4666</issn><issn>1096-0023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9u1DAQhy0EoqXwAhyQj1yy-E9iJxKXagW0UiUu5Ww5k9nixbGDHa-ah-FdSdjCkdPMyN_85NFHyFvOdpxx9eG4g2WOO8F4t-NN3Sr1jFxy1qmKMSGfb30tq1opdUFe5XxkjHVS65fkQnIlOs7kJfm1jxU-TglzdjHQeKC3YcbksfxwoeL6mo7RIxRvE7XDsZxsmKkNA51SnL4v3sLsgN6gdxD7dcBEp8XH5OgDBtzeThbABaQQix8o2JKR5pVzHqkbxxLcvFAX6H3CB5rL9OcvONDRAb4mLw7WZ3zzVK_It8-f7vc31d3XL7f767sKZKPmCphWrUDeHHTbdF3f1MCFUtgryaHRmmGtZK-1RMn7um5ZW6-d4oMQnLeA8oq8P-euV_0smGczugzovQ0YSzZCMs2l5p1YUXFGIcWcEx7MlNxo02I4M5sWczSbFrNpMWct69K7p_zSjzj8W_nrYQU-ngFcrzw5TCaDwwA4uIQwmyG6_-X_Bn1soKg</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Nemattalab, Mehran</creator><creator>Shenagari, Mohammad</creator><creator>Taheri, Mojtaba</creator><creator>Mahjoob, Mohammad</creator><creator>Nazari Chamaki, Foroogh</creator><creator>Mojtahedi, Ali</creator><creator>Hasan-alizadeh, Elham</creator><creator>Ashrafkhani, Babak</creator><creator>Mousavi Niri, Neda</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202002</creationdate><title>Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice</title><author>Nemattalab, Mehran ; Shenagari, Mohammad ; Taheri, Mojtaba ; Mahjoob, Mohammad ; Nazari Chamaki, Foroogh ; Mojtahedi, Ali ; Hasan-alizadeh, Elham ; Ashrafkhani, Babak ; Mousavi Niri, Neda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-c07682e15f78599b54c1266eb631c5770e463b773e31b448084e3161d22118ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adjuvants, Immunologic</topic><topic>Animals</topic><topic>Helicobacter Infections - prevention &amp; control</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - immunology</topic><topic>Hepatocyte Nuclear Factor 3-gamma - immunology</topic><topic>IL-17A</topic><topic>IL-18</topic><topic>IL-22</topic><topic>Immunoglobulin G - blood</topic><topic>Interferon-gamma - blood</topic><topic>Interferon-gamma - genetics</topic><topic>Interferon-gamma - metabolism</topic><topic>Interleukin-17 - blood</topic><topic>Interleukin-17 - genetics</topic><topic>Interleukin-17 - metabolism</topic><topic>Interleukin-18 - blood</topic><topic>Interleukin-18 - genetics</topic><topic>Interleukin-18 - metabolism</topic><topic>Interleukin-2 - blood</topic><topic>Interleukin-2 - genetics</topic><topic>Interleukin-22</topic><topic>Interleukin-4 - blood</topic><topic>Interleukin-4 - genetics</topic><topic>Interleukin-8 - blood</topic><topic>Interleukin-8 - genetics</topic><topic>Interleukins - blood</topic><topic>Interleukins - genetics</topic><topic>Interleukins - metabolism</topic><topic>Mice</topic><topic>Recombinant Proteins</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><topic>T-Lymphocytes, Regulatory - metabolism</topic><topic>Th1 Cells - immunology</topic><topic>Th17 Cells - immunology</topic><topic>Th2 Cells - immunology</topic><topic>Treg</topic><topic>Vaccine</topic><topic>Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nemattalab, Mehran</creatorcontrib><creatorcontrib>Shenagari, Mohammad</creatorcontrib><creatorcontrib>Taheri, Mojtaba</creatorcontrib><creatorcontrib>Mahjoob, Mohammad</creatorcontrib><creatorcontrib>Nazari Chamaki, Foroogh</creatorcontrib><creatorcontrib>Mojtahedi, Ali</creatorcontrib><creatorcontrib>Hasan-alizadeh, Elham</creatorcontrib><creatorcontrib>Ashrafkhani, Babak</creatorcontrib><creatorcontrib>Mousavi Niri, Neda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cytokine (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nemattalab, Mehran</au><au>Shenagari, Mohammad</au><au>Taheri, Mojtaba</au><au>Mahjoob, Mohammad</au><au>Nazari Chamaki, Foroogh</au><au>Mojtahedi, Ali</au><au>Hasan-alizadeh, Elham</au><au>Ashrafkhani, Babak</au><au>Mousavi Niri, Neda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice</atitle><jtitle>Cytokine (Philadelphia, Pa.)</jtitle><addtitle>Cytokine</addtitle><date>2020-02</date><risdate>2020</risdate><volume>126</volume><spage>154866</spage><epage>154866</epage><pages>154866-154866</pages><artnum>154866</artnum><issn>1043-4666</issn><eissn>1096-0023</eissn><abstract>•The development of H. pylori vaccine became a priority in the field of vaccinology.•The research was aimed at determining the role of some cytokines in H. pylori vaccine development.•Either oipA alone, or oipA co-expressed with cytokines, promotes protective immunity.•The highest Th17 cytokines were produced in Treg suppressed IL-17A receiving group.•Treg suppressed mice administered with IL-17A/oipA developed sterile immunity. The increasing clinical significance of Helicobacter pylori (H. pylori) in human stomach cancer has led to global efforts to eradicate this pathogen. Recent studies have confirmed the importance of some cytokines such as Interleukin-18 (IL-18), Interleukin-8 (IL-8), Interleukin-17A (IL-17A) and Interleukin-22 (IL-22) in the pathogenesis of the so-called bacterium. This study was designed to compare the effects of Type 1T helper (Th1), Type 2T helper (Th2) cells, Regulatory T cells (Treg) and T helper 17 (Th17) modulatory effects on the efficacy of designed H. pylori vaccine by incorporating some molecular adjuvants in Treg competent and Treg suppressed groups. A bicistronic vector was used for simultaneous expression of codon-optimized Outer inflammatory protein a (OipA) gene and modified mice IL-18, IL-17A, IL-22 and Foxp3 (forkhead box P3) cytokines from four cassettes. Immunization of mice groups was performed using produced plasmids intradermally. Specific IgG1 and IgG2 and IgA antibody titers produced in mice were confirmed by enzyme-linked immunosorbent assay (ELISA) in sera and intestine obtained four weeks after the last immunization. After being stimulated with a mixture of both anti-CD28 mAb and H. pylori lysate, frequencies of single Interferon-Gamma (IFN-γ), single IL-17 and dual IFN-γ/IL-17-secreting T-cells were documented using dual-color FluoroSpot. The kinetics of Th1, Th2 and Th17 in the immunized animals was determined by relative quantification of IL-17A, IL-22, IFN-γ, IL-8, IL-2 and IL-4 specific mRNAs. Four weeks after bacterial challenge, quantitative colony count in the isolated and homogenized stomachs was utilized to assess the level of protective immunity among all groups. The results of immunologic assays showed that the highest cell-mediated immunity cytokines were produced in IL-17 receiving group in which the Treg responses were suppressed previously by the administration of the Foxp3 as an immunogen. In addition, potent clearance of Helicobacter pylori infection was seen in this group as well.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31629103</pmid><doi>10.1016/j.cyto.2019.154866</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-4666
ispartof Cytokine (Philadelphia, Pa.), 2020-02, Vol.126, p.154866-154866, Article 154866
issn 1043-4666
1096-0023
language eng
recordid cdi_proquest_miscellaneous_2307137192
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adjuvants, Immunologic
Animals
Helicobacter Infections - prevention & control
Helicobacter pylori
Helicobacter pylori - immunology
Hepatocyte Nuclear Factor 3-gamma - immunology
IL-17A
IL-18
IL-22
Immunoglobulin G - blood
Interferon-gamma - blood
Interferon-gamma - genetics
Interferon-gamma - metabolism
Interleukin-17 - blood
Interleukin-17 - genetics
Interleukin-17 - metabolism
Interleukin-18 - blood
Interleukin-18 - genetics
Interleukin-18 - metabolism
Interleukin-2 - blood
Interleukin-2 - genetics
Interleukin-22
Interleukin-4 - blood
Interleukin-4 - genetics
Interleukin-8 - blood
Interleukin-8 - genetics
Interleukins - blood
Interleukins - genetics
Interleukins - metabolism
Mice
Recombinant Proteins
T-Lymphocytes, Regulatory - immunology
T-Lymphocytes, Regulatory - metabolism
Th1 Cells - immunology
Th17 Cells - immunology
Th2 Cells - immunology
Treg
Vaccine
Vaccines - immunology
title Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T14%3A16%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Co-expression%20of%20Interleukin-17A%20molecular%20adjuvant%20and%20prophylactic%20Helicobacter%20pylori%20genetic%20vaccine%20could%20cause%20sterile%20immunity%20in%20Treg%20suppressed%20mice&rft.jtitle=Cytokine%20(Philadelphia,%20Pa.)&rft.au=Nemattalab,%20Mehran&rft.date=2020-02&rft.volume=126&rft.spage=154866&rft.epage=154866&rft.pages=154866-154866&rft.artnum=154866&rft.issn=1043-4666&rft.eissn=1096-0023&rft_id=info:doi/10.1016/j.cyto.2019.154866&rft_dat=%3Cproquest_cross%3E2307137192%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2307137192&rft_id=info:pmid/31629103&rft_els_id=S1043466619302959&rfr_iscdi=true